Nuzzo, Silvia (2018) Selection of aptamers targeting a hypoxia marker: Carbonic Anhydrase-IX (CA-IX). [Tesi di dottorato]

[thumbnail of Silvia_Nuzzo_XXX_ciclo_Doctorate_in_Molecular_Medicine_and_Medical_Biotechnology_short_version.pdf]
Preview
Text
Silvia_Nuzzo_XXX_ciclo_Doctorate_in_Molecular_Medicine_and_Medical_Biotechnology_short_version.pdf

Download (932kB) | Preview
[thumbnail of Silvia_Nuzzo_XXX_ciclo_Doctorate_in_Molecular_Medicine_and_Medical_Biotechnology_long_version_.pdf]
Preview
Text
Silvia_Nuzzo_XXX_ciclo_Doctorate_in_Molecular_Medicine_and_Medical_Biotechnology_long_version_.pdf

Download (2MB) | Preview
Item Type: Tesi di dottorato
Resource language: English
Title: Selection of aptamers targeting a hypoxia marker: Carbonic Anhydrase-IX (CA-IX)
Creators:
Creators
Email
Nuzzo, Silvia
nuzzo.silvia@gmail.com
Date: 2018
Number of Pages: 94
Institution: Università degli Studi di Napoli Federico II
Department: dep14
Dottorato: phd054
Ciclo di dottorato: 30
Coordinatore del Corso di dottorato:
nome
email
Avvedimento, Vittorio Enrico
vittorioenrico.avvedimento@unina.it
Tutor:
nome
email
de Franciscis, Vittorio
UNSPECIFIED
Date: 2018
Number of Pages: 94
Keywords: aptamers, hypoxia
Settori scientifico-disciplinari del MIUR: Area 06 - Scienze mediche > MED/04 - Patologia generale
Date Deposited: 27 Dec 2017 23:52
Last Modified: 25 Jul 2020 01:00
URI: http://www.fedoa.unina.it/id/eprint/12248

Collection description

Aptamers are selected by an in vitro combinatorial chemistry approach, named Systematic Evolution of Ligands by Exponential enrichment (SELEX), and they are able to bind with high affinity and specificity virtually any given molecule. Compared to monoclonal antibodies, they have a small size that results in their rapid tumour penetration; they are not immunogenic and could be easily modified to increase their in vivo stability. Thus, in this study we describe the selection of RNA-based aptamers directed against an hypoxic biomarker. Firstly, we performed two different cell-based SELEX protocols that allowed the specific enrichment for the target. Furthermore, we characterized and improved the two best sequences selected, named S-47s1 and S-51s1, that we are still studying to handle a final product usable for diagnostic and therapeutic purposes.

Downloads

Downloads per month over past year

Actions (login required)

View Item View Item